Carla Nester

10.9k total citations · 1 hit paper
85 papers, 3.1k citations indexed

About

Carla Nester is a scholar working on Immunology, Nephrology and Hematology. According to data from OpenAlex, Carla Nester has authored 85 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Immunology, 53 papers in Nephrology and 24 papers in Hematology. Recurrent topics in Carla Nester's work include Complement system in diseases (57 papers), Renal Diseases and Glomerulopathies (52 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers). Carla Nester is often cited by papers focused on Complement system in diseases (57 papers), Renal Diseases and Glomerulopathies (52 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers). Carla Nester collaborates with scholars based in United States, Spain and United Kingdom. Carla Nester's co-authors include James N. George, Richard J. Smith, Christie P. Thomas, Sanjeev Sethi, Nicole C. Meyer, Yuzhou Zhang, Santiago Rodrı́guez de Córdoba, Véronique Frémeaux‐Bacchi, Matthew C. Pickering and Marina Noris and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Blood.

In The Last Decade

Carla Nester

70 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Syndromes of Thrombotic Microangiopathy

2014 787 citations Carla Nester et al. profile →

Peers

Countries citing papers authored by Carla Nester

Since Specialization

Citations

This map shows the geographic impact of Carla Nester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carla Nester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carla Nester more than expected).

Fields of papers citing papers by Carla Nester

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carla Nester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carla Nester. The network helps show where Carla Nester may publish in the future.

Co-authorship network of co-authors of Carla Nester

This figure shows the co-authorship network connecting the top 25 collaborators of Carla Nester. A scholar is included among the top collaborators of Carla Nester based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carla Nester. Carla Nester is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessing C3 nephritic factor function using Luminex-based formation and stabilization assays 2025 ·Immunobiology ·(unknown), (unknown), (unknown), (unknown), Richard Smith, Carla Nester	0
2	Antibodies in the healthy population influence convertase formation 2025 ·Immunobiology ·(unknown), Carla Nester	0
3	Detecting FH–anti-FH immune complexes in MGRS-C3G 2025 ·Immunobiology ·(unknown), Sarah M. Roberts, Stuart S. Martin, Suzanne F. Cook, Carla Nester, (unknown), Santiago Rodrı́guez de Córdoba, Richard J. Smith, Yuzhou Zhang	0
4	#3391 Pegcetacoplan treatment appears to halt disease progression in C3G and primary (idiopathic) IC-MPGN patients: results from the phase 3 VALIANT study 2025 ·Nephrology Dialysis Transplantation ·Daniel P. Gale, Andrew S. Bomback, Christoph Licht, Carla Nester, Matthew C. Pickering, Giuseppe Remuzzi, Nicole C. A. J. van de Kar, (unknown), Johan Szamosi, (unknown), Luis Fernando Barba-Gallardo, Fádi Fakhouri	1
5	#277 Update to the long-term safety and efficacy of iptacopan in C3G: 33-month extension study data from patients enrolled in a phase 2 study 2024 ·Nephrology Dialysis Transplantation ·Carla Nester, Ute Eisenberger, Alexandre Karras, Moglie Le Quintrec, Liz Lightstone, Manuel Praga, Giuseppe Remuzzi, María José Soler Romeo, Junhao Liu, Matthias Meier, Nicholas J.A. Webb, Edwin Wong	0
6	Iptacopan Reduces Proteinuria and Stabilizes Kidney Function in C3 Glomerulopathy 2024 ·Kidney International Reports ·Carla Nester, Ute Eisenberger, Alexandre Karras, Moglie Le Quintrec, Liz Lightstone, Manuel Praga, Giuseppe Remuzzi, María José Soler, Junhao Liu, Matthias Meier, (unknown), G. Junge, Andrea Biondani, Angelo J. Trapani, Nicholas J.A. Webb, Edwin Wong	2
7	Defining Nephritic Factors as Diverse Drivers of Systemic Complement Dysregulation in C3 Glomerulopathy 2023 ·Kidney International Reports ·(unknown), (unknown), (unknown), Amanda Taylor, Nicole C. Meyer, Sarah M. Roberts, (unknown), (unknown), Nicolò Ghiringhelli Borsa, (unknown), Carla Nester, Richard J. Smith	8
8	Renin and renin blockade have no role in complement activity 2023 ·Kidney International ·Yuzhou Zhang, (unknown), M. Ashley Spies, Sarah M. Roberts, (unknown), (unknown), (unknown), (unknown), (unknown), Carla Nester, Richard J. Smith	4
9	Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan 2022 ·American Journal of Nephrology ·Steven D. Podos, Howard Trachtman, Gerald B. Appel, Andrew S. Bomback, Bradley P. Dixon, Jack F.M. Wetzels, H. Terence Cook, Samir V. Parikh, Matthew C. Pickering, (unknown), Craig B. Langman, Liz Lightstone, C. John Sperati, Erica Daina, (unknown), Kara Rice, Jane A. Thanassi, Mingjun Huang, Carla Nester, Giuseppe Remuzzi	11
10	A Mutation in Complement Factor B Causing Massive Fluid-Phase Dysregulation of the Alternative Complement Pathway Can Result in Atypical Hemolytic Uremic Syndrome 2020 ·Journal of the American Society of Nephrology ·Yuzhou Zhang, (unknown), C. John Sperati, Kammi Henriksen, Mari Mori, (unknown), (unknown), Nicolò Ghiringhelli Borsa, Ronald P. Taylor, Carla Nester, Richard J. Smith	0
11	Factor H Autoantibodies and Complement-Mediated Diseases 2020 ·Frontiers in Immunology ·Yuzhou Zhang, Nicolò Ghiringhelli Borsa, (unknown), (unknown), (unknown), Nicole C. Meyer, (unknown), Amanda Taylor, Carla Nester, Christoph Q. Schmidt, Richard J. Smith	27
12	Genetic Analysis of 400 Patients Refines Understanding and Implicates a New Gene in Atypical Hemolytic Uremic Syndrome 2018 ·Journal of the American Society of Nephrology ·Fengxiao Bu, Yuzhou Zhang, Kai Wang, Nicolò Ghiringhelli Borsa, M. B. Jones, Amanda Taylor, (unknown), Nicole C. Meyer, Kathy Frees, Christie P. Thomas, Carla Nester, Richard J. Smith	48
13	High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies 2015 ·Journal of the American Society of Nephrology ·Fengxiao Bu, Nicolò Ghiringhelli Borsa, M. B. Jones, (unknown), Carla Nishimura, (unknown), Héla Azaiez, E. Ann Black-Ziegelbein, Nicole C. Meyer, Diana L. Kolbe, Yingyue Li, Kathy Frees, Michael J. Schnieders, Christie P. Thomas, Carla Nester, Richard J. Smith	74
14	Atypical aHUS: State of the art 2015 ·Molecular Immunology ·Carla Nester, Thomas Barbour, Santiago Rodrı́guez de Córdoba, Marie‐Agnès Dragon‐Durey, Véronique Frémeaux‐Bacchi, Tim Goodship, David Kavanagh, Marina Noris, Matthew C. Pickering, Pilar Sánchez‐Corral, Christine Skerka, Peter F. Zipfel, Richard J. Smith	206
15	Defining the Complement Biomarker Profile of C3 Glomerulopathy 2014 ·Clinical Journal of the American Society of Nephrology ·Yuzhou Zhang, Carla Nester, (unknown), Mikkel‐Ole Skjoedt, Nicole C. Meyer, (unknown), Nicolò Ghiringhelli Borsa, Yaseelan Palarasah, Richard J. Smith	66
16	Comprehensive Genetic Analysis of Complement and Coagulation Genes in Atypical Hemolytic Uremic Syndrome 2013 ·Journal of the American Society of Nephrology ·Fengxiao Bu, Tara Maga, Nicole C. Meyer, Kai Wang, Christie P. Thomas, Carla Nester, Richard J. Smith	161
17	Proliferative Glomerulonephritis Secondary to Dysfunction of the Alternative Pathway of Complement 2011 ·Clinical Journal of the American Society of Nephrology ·Sanjeev Sethi, Fernando C. Fervenza, Yuzhou Zhang, Samih H. Nasr, Nelson Leung, Julie A. Vrana, Carl H. Cramer, Carla Nester, Richard J. Smith	113
18	Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion 2011 ·Kidney International ·Sanjeev Sethi, Carla Nester, Richard J. Smith	143
19	Pre-emptive Eculizumab and Plasmapheresis for Renal Transplant in Atypical Hemolytic Uremic Syndrome 2011 ·Clinical Journal of the American Society of Nephrology ·Carla Nester, Zoe A. Stewart, David T. Myers, Jennifer G. Jetton, Ramesh Nair, Alan Reed, Christie P. Thomas, Richard J. Smith, Patrick D. Brophy	97
20	Counseling to Promote a Healthy Diet 2001 ·Alice S. Ammerman, Michael Pignone, (unknown), Kathleen N Lohr, (unknown), Carla Nester, Tracy Orleans, Niall Pender, Steven H. Woolf, (unknown), (unknown), (unknown)	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact